tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OXBDF Stock Latest News

Oxford Biomedica Announces Share Transaction by Associated Person
Company AnnouncementsOxford Biomedica Announces Share Transaction by Associated Person
5d ago
Oxford BioMedica Sees Change in Major Shareholder Voting Rights
PremiumCompany Announcements
Oxford BioMedica Sees Change in Major Shareholder Voting Rights
6d ago
Oxford Biomedica Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Oxford Biomedica Announces 2025 Annual General Meeting Details
7d ago
Oxford BioMedica Sees Stake Increase by Briarwood Chase Management
PremiumCompany Announcements
Oxford BioMedica Sees Stake Increase by Briarwood Chase Management
12d ago
Oxford Biomedica price target raised to 800 GBp from 740 GBp at RBC Capital
PremiumThe Fly
Oxford Biomedica price target raised to 800 GBp from 740 GBp at RBC Capital
21d ago
Oxford Biomedica Reports Strong 2024 Financial Performance
PremiumCompany AnnouncementsOxford Biomedica Reports Strong 2024 Financial Performance
25d ago
Oxford Biomedica’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Oxford Biomedica’s Earnings Call Highlights Growth and Challenges
25d ago
Oxford Biomedica prepares statements on ‘going concern basis’
Premium
The Fly
Oxford Biomedica prepares statements on ‘going concern basis’
26d ago
Oxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last year
PremiumThe Fly
Oxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last year
26d ago
Oxford Biomedica vice chair Stuart Henderson to retire
PremiumThe Fly
Oxford Biomedica vice chair Stuart Henderson to retire
26d ago
Oxford Biomedica sees FY25 revenue GBP 160M-GBP 170M
PremiumThe Fly
Oxford Biomedica sees FY25 revenue GBP 160M-GBP 170M
26d ago
Oxford BioMedica: Promising Growth and Attractive Valuation Drive Buy Rating
PremiumRatings
Oxford BioMedica: Promising Growth and Attractive Valuation Drive Buy Rating
26d ago
Oxford BioMedica Reports Robust 2024 Financial Performance and Strategic Expansion
PremiumCompany AnnouncementsOxford BioMedica Reports Robust 2024 Financial Performance and Strategic Expansion
26d ago
Briarwood Chase Increases Stake in Oxford BioMedica
Premium
Company Announcements
Briarwood Chase Increases Stake in Oxford BioMedica
1M ago
Oxford Biomedica’s Colin Bond Joins Faron Pharmaceuticals as Non-Executive Director
Premium
Company Announcements
Oxford Biomedica’s Colin Bond Joins Faron Pharmaceuticals as Non-Executive Director
1M ago
Oxford Biomedica Announces Total Voting Rights
PremiumCompany Announcements
Oxford Biomedica Announces Total Voting Rights
2M ago
Oxford Biomedica to Present at Global Healthcare Conference
PremiumCompany Announcements
Oxford Biomedica to Present at Global Healthcare Conference
2M ago
M&G Plc Increases Stake in Oxford BioMedica
PremiumCompany Announcements
M&G Plc Increases Stake in Oxford BioMedica
2M ago
Oxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trial
PremiumThe Fly
Oxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trial
2M ago
Oxford Biomedica Supports Boehringer Ingelheim’s Cystic Fibrosis Gene Therapy Trial
PremiumCompany AnnouncementsOxford Biomedica Supports Boehringer Ingelheim’s Cystic Fibrosis Gene Therapy Trial
2M ago
Oxford BioMedica Announces Change in Major Holdings
Premium
Company Announcements
Oxford BioMedica Announces Change in Major Holdings
2M ago
Oxford BioMedica: Poised for Growth with Strong Financial Trajectory and Attractive Valuation
Premium
Ratings
Oxford BioMedica: Poised for Growth with Strong Financial Trajectory and Attractive Valuation
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >